Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
19
2026

Are Skin Cancer Risk Factors Different for Men and Women?

Skin cancer usually starts from spending too much time under the sun’s powerful ultraviolet (UV) rays. Without protecting your skin from these rays, they can damage your DNA – which controls how your cells grow…

January
05
2023

Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues

Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60% BOCA RATON, Fla, Jan. 05, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing…

November
03
2022

Sensus Healthcare Reports Third Quarter 2022 Financial Results

Profitability continues with revenues up 64% to $9.0 million, diluted EPS of $0.11 compares with $0.01 a year ago Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 03, 2022 —…

October
27
2022

Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022

BOCA RATON, Fla., Oct. 27, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

October
20
2022

Sensus Healthcare Introduces Silk™ Laser Hair Removal System

Only portable hair removal laser system with blended wavelengths for all skin phototypes to be launched at the Fall Clinical Dermatology Conference BOCA RATON, Fla, Oct. 20, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry